Physician profile

Christopher M Campus

Dentist · Pensacola, FL

NPI 1548427933

$579.23

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$181.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biohorizons Implant Systems INC. $165.89 2020-2024 Biohorizons
Aerin Medical INC. $157.83 2019
Sprintray INC $136.28 2024 Pro 2 3d Printer
Dentsply Sirona INC $56.49 2019
Keystone Dental INC. $24.63 2019
Pacira Pharmaceuticals Incorporated $24.60 2023 Exparel
Orapharma, A Division of Bausch Health US, LLC $13.51 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher M Campus

$579.23

in general payments reported 2019-2025

Years
2019-2024
Top company
Biohorizons Implant Systems INC.

https://glasscript.com/doctor/25206/christopher-m-campus

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.